Gilotrif

Gilotrif Specification

Salt Composition
Afatinib Dimaleate

Pacakaging (Quantity Per Box)
28 tablets

Origin of Medicine
Imported

Dosage Form
Tablet

Indication
Metastatic non-small cell lung cancer (NSCLC) with EGFR mutations

Drug Type
Allopathic

Ingredients
Afatinib Dimaleate

Physical Form
Tablets

Function
Treatment of non-small cell lung cancer (NSCLC)

Recommended For
Lung cancer patients as directed by a physician

Dosage
40 mg per day or as prescribed by physician

Dosage Guidelines
Follow physicians instructions. Swallow whole with water, do not chew or crush.

Suitable For
Adults

Quantity
28 tablets per box

Storage Instructions
Store below 30C, keep in original package to protect from moisture

Administration Route
Oral

Color
Light blue

Product Registration
Registered medical product

Marketed In
Global (including India, EU, US)

Trade Name
Gilotrif

Warning
Not to be used in pregnancy or breastfeeding unless directed by physician

Prescription/Non Prescription
Prescription

Side Effects
Diarrhea, rash, stomatitis, paronychia, dry skin

Manufactured By
Boehringer Ingelheim

ATC Code
L01XE13

Shelf Life
2 years from date of manufacture

Gilotrif Trade Information

Minimum Order Quantity
10 Packs

FOB Port
Mumbai

Payment Terms
Cash in Advance (CID)

Supply Ability
10 Packs Per Day

Delivery Time
20 Days

Sample Available
Yes

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
As per Order

Main Export Market(s)
Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Asia

Certifications
WHO GMP

About Gilotrif

Gilotrif, manufactured by Boehringer Ingelheim, is a premier oral medication designed for adults with metastatic non-small cell lung cancer (NSCLC) featuring EGFR mutations. This first-class, registered product delivers the affordable advantage of top-tier quality at an unbeatable price, making it an unparalleled bargain for patients and healthcare providers alike. Each box contains 28 light blue tablets of 40 mg Afatinib Dimaleate, featuring a 2-year shelf life. Gilotrif is sourced globallyincluding India, the EU, and USand offers a crackerjack solution in advanced cancer care. Prescription required.

Gilotrif Usage and Application Information

Gilotrif is specifically recommended for adult patients diagnosed with metastatic NSCLC carrying EGFR mutations. As a general-use oncology medication, directions of use are strictly as prescribed by a medical professional. The tablets are to be swallowed whole with water, without chewing or crushing, ensuring optimal absorption. Gilotrif is intended for oral administration only; its application is internal rather than on any external surface, and compliance with each direction issued by your physician is crucial for best results.

Gilotrif Payment, Packaging & Sample Terms

Gilotrif comes securely packaged as 28 light blue tablets per box, maintaining quality with protective original packaging and clear storage guidelines. Customers can expect smooth delivery or prompt drop-off and efficient processing upon order. Typically, arrival of your prescribed medication is arranged within standard timelines, ensuring a seamless experience from purchase to use. Flexible payment terms can be discussed, and samples may be made available for qualified healthcare dealers, exporters, or suppliers to examine product suitability.

FAQs of Gilotrif:

Q: How should Gilotrif be administered?

A: Gilotrif should be taken orally as prescribed by your physician, swallowing the tablet whole with water without chewing or crushing. Follow your doctors dosage and usage instructions precisely.

Q: What is Gilotrif primarily used for?

A: Gilotrif is specifically indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) in adults whose tumors have EGFR mutations.

Q: When should I avoid taking Gilotrif?

A: You should not use Gilotrif during pregnancy or breastfeeding unless instructed by a physician, due to potential risks associated with the medication.

Q: Where is Gilotrif distributed and registered?

A: Gilotrif is a globally marketed and registered medical product, available in India, the EU, the US, and various other countries through authorized suppliers and distributors.

Q: What are the possible side effects of Gilotrif?

A: Some reported side effects include diarrhea, rash, stomatitis, paronychia, and dry skin. Report any side effects to your healthcare provider promptly.

Q: How is Gilotrif packaged and stored?

A: Gilotrif is supplied in boxes of 28 tablets. Store the medication below 30C in the original packaging to protect it from moisture, as directed on the label.